Susquehanna International Group’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$32.4K Sell
2025
Q1
$59.8K Buy
2024
Q4
$92.8K Buy
2023
Q2
Sell
2023
Q1
$739K Buy
2022
Q4
$563K Buy
2022
Q3
$90K Sell
2022
Q2
$154K Buy
2022
Q1
Sell
2021
Q4
$364K Buy
2021
Q3
$613K Buy
2021
Q2
$491K Buy